Treatment News : A Low CD4 Count Despite Low Viral Load Raises Risk of Death

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » February 2014

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

February 19, 2014

A Low CD4 Count Despite Low Viral Load Raises Risk of Death

Those whose CD4 cell levels fail to rise above 200 despite long-term suppression of HIV through antiretroviral (ARV) therapy have a more than doubled risk of death, aidsmap reports. Publishing their findings in Clinical Infectious Diseases, researchers studied 5,550 people with HIV from 53 European and North American cohorts who had CD4 counts at or below 200 before starting HIV treatment and who maintained a viral load at or below 500 for more than three years.

A total of 835 (15 percent) of the study participants did not see their CD4 counts rise above 200 after three years of viral suppression. Factors associated with these persistently low CD4 counts included increased age, being a male heterosexual or an injection drug user, having a viral load below 100,000 or a relatively low CD4 count upon starting treatment, and taking longer after starting ARVs to achieve a suppressed viral load.

There were 175 deaths in the study. Those whose CD4s did not rise above 200 had a mortality rate of 8 percent, compared with just 2 percent among those who did. Adjusting for various factors, the investigators found those who remained below the 200 CD4 count threshold had a 2.6-times greater likelihood of death when compared with those whose CD4 counts rose above that mark.

To read the aidsmap story, click here.

To read the study abstract, click here.

Search: Low CD4 count, suppressed viral load, HIV, mortality risk, risk of death, Clinical Infectious Diseases, aidsmap.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chrisf
    san jose
    California


    july8th69
    brooklyn
    New York


    cortaza100
    Chicago
    Illinois


    albsur7436
    San Francisco
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you work with your doc to design your own treatment regimen?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.